Fellow-Eye Comparison between Phaco-Microhook Ab-Interno Trabeculotomy and Phaco-iStent Trabecular Micro-Bypass Stent
Yuji Takayanagi1, Sho Ichioka1, Akiko Ishida1
1Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo 693-8501, Japan.
Journal of Clinical Medicine
|June 2, 2021
Summary
Microhook ab-interno trabeculotomy (µLOT) demonstrated superior intraocular pressure (IOP) reduction and medication decrease compared to iStent implantation when combined with cataract surgery. While µLOT showed a higher incidence of anterior chamber flare and hyphema, it achieved better IOP control.
Area of Science:
- Ophthalmology
- Glaucoma Surgery
- Minimally Invasive Glaucoma Surgery (MIGS)
Background:
- Glaucoma management often requires surgical intervention to lower intraocular pressure (IOP).
- Microhook ab-interno trabeculotomy (µLOT) and iStent trabecular micro-bypass stent implantation are MIGS procedures.
- Combining MIGS with cataract surgery is a common approach for patients with coexisting conditions.
Purpose of the Study:
- To compare the surgical efficacy and safety of µLOT versus iStent implantation.
- To evaluate outcomes when both procedures are combined with cataract surgery.
- To assess IOP reduction, medication usage, visual acuity, and safety profiles.
Main Methods:
- Retrospective study including 64 glaucomatous eyes from 32 participants.
- Fellow-eye comparison of µLOT and iStent implantation combined with cataract surgery.
- Evaluation of IOP, antiglaucoma medications, BCVA, ACF, and CECD at multiple postoperative time points.
Main Results:
- Both µLOT and iStent significantly reduced IOP and medication use post-surgery.
- µLOT achieved a greater IOP reduction (29.5%) and medication decrease (0.7) at 12 months compared to iStent (15.6%, 0.4).
- µLOT showed a higher IOP control survival rate (40.6% vs. 18.8%) but also a greater frequency of layered hyphema (25% vs. 0%) and anterior chamber flare.
Conclusions:
- µLOT is more effective than iStent in reducing IOP and medication burden when combined with cataract surgery.
- While µLOT has a higher risk of transient complications like hyphema and anterior chamber flare, its efficacy in IOP lowering is superior.
- Both procedures demonstrated comparable effects on best-corrected visual acuity and corneal endothelial cell density.
Related Concept Videos
Angle Closure Glaucoma: Treatment
906
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
906
Open Angle Glaucoma: Treatment
779
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
779


